We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$78.8B
AUM Growth
+$7.07B
Cap. Flow
+$2.22B
Cap. Flow %
2.81%
Top 10 Hldgs %
22%
Holding
3,838
New
237
Increased
1,800
Reduced
1,491
Closed
179

Sector Composition

Rank Sector Weight
1 Technology 11.07%
2 Financials 9.56%
3 Healthcare 8.56%
4 Industrials 6.35%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBM icon
3451
Hudbay
HBM
$12.4B
$97K ﹤0.01%
23,364
-1,575
-6% -$5.7K
ACH
3452
Accendra Health
ACH
$107M
$97K ﹤0.01%
18,809
-1,041
-5% -$6.68K
UNP icon
3453
CALL
Union Pacific
UNP
$174B
$95K ﹤0.01%
70,000
-28,100
-29% -$4.81M
AUY
3454
DELISTED
Yamana Gold, Inc.
AUY
$93K ﹤0.01%
23,576
+242
+1% +$850
FOMX
3455
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$93K ﹤0.01%
27,800
-300
-1% -$954
GEN
3456
DELISTED
Genesis Healthcare, Inc.
GEN
$90K ﹤0.01%
55,000
TBIO
3457
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$89K ﹤0.01%
10,991
-8,679
-44% -$80.1K
CLNE icon
3458
Clean Energy Fuels
CLNE
$355M
$88K ﹤0.01%
37,585
-8,115
-18% -$17.2K
RYAM icon
3459
Rayonier Advanced Materials
RYAM
$593M
$87K ﹤0.01%
22,658
-13,392
-37% -$54.7K
CMCSA icon
3460
CALL
Comcast
CMCSA
$89.4B
$86K ﹤0.01%
469,700
+208,000
+79% +$9.26M
SOS
3461
SOS Limited
SOS
$14.4M
$86K ﹤0.01%
31
-33
-52% -$70.2K
TGS icon
3462
Transportadora de Gas del Sur
TGS
$4.41B
$86K ﹤0.01%
11,944
-8,190
-41% -$56.9K
VSTM icon
3463
Verastem
VSTM
$615M
$86K ﹤0.01%
5,355
+188
+4% +$2.7K
XCUR icon
3464
Exicure
XCUR
$8.73M
$86K ﹤0.01%
200
NBR icon
3465
Nabors Industries
NBR
$1.33B
$85K ﹤0.01%
588
-1,157
-66% -$122K
RMTI icon
3466
Rockwell Medical
RMTI
$27M
$84K ﹤0.01%
313
-35
-10% -$8.8K
BBBY
3467
CALL
DELISTED
Bed Bath & Beyond Inc
BBBY
$83K ﹤0.01%
+32,300
New +$452K
AMSC icon
3468
American Superconductor
AMSC
$1.5B
$82K ﹤0.01%
10,500
MET icon
3469
CALL
MetLife
MET
$61.7B
$82K ﹤0.01%
59,900
+1,100
+2% +$53.1K
NOVN
3470
DELISTED
Novan, Inc. Common Stock
NOVN
$82K ﹤0.01%
2,604
-50
-2% -$1.17K
ENB icon
3471
CALL
Enbridge
ENB
$112B
$81K ﹤0.01%
33,000
-100
-0.3% -$3.73K
EOD
3472
Allspring Global Dividend Opportunity Fund
EOD
$286M
$81K ﹤0.01%
14,248
+10
+0.1% +$55
NIO icon
3473
NIO
NIO
$12.1B
$81K ﹤0.01%
20,186
-14,530
-42% -$29.2K
PSCE icon
3474
Invesco S&P SmallCap Energy ETF
PSCE
$103M
$80K ﹤0.01%
2,145
-547
-20% -$18.1K
GALT icon
3475
Galectin Therapeutics
GALT
$315M
$79K ﹤0.01%
27,740
+650
+2% +$2.26K

Similar funds

Raymond James & Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Raymond James & Associates held 3,838 positions worth $78.8B, up 9.9% from $71.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Raymond James & Associates's Q4 2019 filing shows 237 new, 1,800 increased, 1,491 reduced and 179 closed positions. Its largest new stake was Direxion Daily S&P 500 Bear 1X ETF: 343,036 shares worth $8.38M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $325M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2019 buy was Direxion Daily S&P 500 Bear 1X ETF: 343,036 shares worth $8.38M.
  • Raymond James & Associates added most to Vanguard High Dividend Yield ETF in Q4 2019, an estimated $672M increase.
  • Raymond James & Associates's biggest Q4 2019 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $325M.
  • Raymond James & Associates fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $45.9M.
  • Raymond James & Associates's ten largest holdings make up 22% of its $78.8B portfolio in Q4 2019.
  • Raymond James & Associates opened 237 new positions and closed 179 in Q4 2019.
  • Raymond James & Associates's portfolio value rose 9.9% quarter-over-quarter to $78.8B.

Based on Raymond James & Associates's 13F filing for Q4 2019, filed 12 Feb 2020.